The Telehealth Business Model Explained: How Modern Platforms Actually Make Money

TLDR

The telemedicine market reached $114.98 billion in 2023 and is projected to grow at a 17.96% CAGR through 2030. But "telehealth" isn't a single business model — it's a category with radically different approaches to revenue, delivery, and scale. Understanding which model fits your goals is the difference between a sustainable platform and an expensive compliance project.

The 5 Core Telehealth Business Models

Every telehealth business ultimately falls into one of five revenue architectures:

1. Direct-to-Consumer (DTC) Subscription: Patients pay a monthly fee for unlimited or tiered access. Hims & Hers built $1.48B in 2024 revenue primarily on this model — converting episodic care into a recurring subscription stream.

2. Pay-Per-Consultation: Patients pay per visit without a recurring commitment. Higher per-visit revenue but lower lifetime value and more volatile month-to-month cash flow.

3. Employer/B2B: Telehealth access bundled into employee benefits packages. Stable, predictable contract revenue but longer sales cycles and reliance on HR procurement.

4. Insurance-Integrated: Providers bill payers for reimbursable telehealth visits. Highest per-visit revenue potential but requires credentialing, complex billing, and payer relationships.

5. White-Label Platform-as-a-Service: Non-clinical operators license a turnkey telehealth infrastructure under their brand. FUSE Health operates this model — enabling wellness brands, med spas, and e-commerce operators to offer compliant prescription programs without building clinical infrastructure.

Why the DTC Subscription Model Dominates in 2025

The true innovation of platforms like Hims & Hers and Ro isn't telemedicine — it's the conversion of episodic care into a subscription revenue stream. In a traditional model, a patient visits a doctor, gets a prescription, and refills it sporadically. In the DTC model, the default is a recurring shipment. Subscription models deliver three advantages that compound over time: predictable cash flow, lower patient acquisition cost amortized over a long LTV, and higher adherence rates. Hims & Hers reported 85% subscriber retention and a customer LTV that justifies a $929 CAC.

The Unit Economics of a Telehealth Business

A small-to-medium telehealth business targeting 1,000 patient visits per month at $100 per consult generates $100K in revenue. However, clinical compensation ($124K/month), credentialing ($200 per payer), malpractice insurance ($24,000 per provider annually), and technology costs can make profitability elusive at low volumes. The fastest path to profitability: outsource non-core clinical functions — credentialing, provider staffing, pharmacy logistics — and focus capital on patient acquisition.

How White-Label Telehealth Changes the Economics

White-label telehealth platforms like FUSE Health restructure the unit economics entirely. Instead of building clinical infrastructure, operators pay a platform fee and earn margin on the service fee they set for their patients. Licensed providers, pharmacy integrations, and HIPAA-compliant workflows are provided by the platform. The operator's capital goes entirely toward brand-building and customer acquisition — the highest-ROI activities in the DTC model.

Which Model Is Right for You?

If you're a licensed clinical operator with existing patients: an insurance-integrated or hybrid model maximizes per-visit revenue. If you're a wellness brand, e-commerce operator, or non-licensed entrepreneur: a white-label DTC subscription model removes the clinical and regulatory burden and gets you to revenue faster. If you're an employer or benefits platform: the B2B model offers stable recurring contracts with enterprise clients.